The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...
A recent meta-analysis investigating cardiovascular complications in adults undergoing chimeric antigen receptor (CAR) T-cell ...
Medpage Today on MSN3d
CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy RecordA CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in treatment-refractory ...
Acute kidney injury is being redefined as a collection of syndromes, each of which could be targeted by specific biomarkers.
GlobalData on MSN1d
Autolus secures FDA approval for CAR-T cell therapy use in ALLAutolus Therapeutics has secured US Food and Drug Administration (FDA) approval for Aucatzyl (obecaktagene autoleucel), its ...
AIN is a well-known complication of therapy with a number ... presented to the same institution and developed acute kidney injury (AKI) most likely secondary to nafcillin-associated AIN (see ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback